ONC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 30.97%

Insider Buying (Last 12 Months): GBX 0

Insider Selling (Last 12 Months): GBX 0

Oncimmune Insider Trading History Chart

Oncimmune Share Price & Price History

GBX 0

+0.30 (1.20%)

As of 03/17/2025 01:00 AM ET

Days: 30 | 90 | 365

Oncimmune Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/8/2023	Martin Gouldstone	Insider	Buy	36,023	GBX 27	£9,726.21
6/5/2023	Adam Hill	Insider	Buy	48,370	GBX 21	£10,157.70

SEC Filings (Institutional Ownership Changes) for Oncimmune (LON:ONC)

24.98% of Oncimmune stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Leeds, the United Kingdom.

Today's Range

Now: N/A

50 Day Range

MA: GBX 1.46

1.14

3.10

52 Week Range

Now: N/A

Volume

N/A

Average Volume

589,365 shs

Market Capitalization

£1.29 million

P/E Ratio

0.13

Dividend Yield

N/A

Beta

1.19